Earnings Call · Q4 FY2022·2023-03-30

Q4 22EPS +7.14%·Rev n/aQ3 22EPS +9.52%·Rev n/aQ2 22EPS -26.67%·Rev n/aQ1 22EPS -15.38%·Rev n/a⚠ consensus missing

BRAINSTORM CELL THERAPEUTICS INC. BCLI

Michael Wood — Investor Relations or Communications

Chaim Lebovits — Chief Executive Officer

Stacy Lindborg — Chief Medical Officer

Alla Patlis — Chief Financial Officer

+2.5%1d on move date+1.9% vs SPY3d+22.5%5d+15.6%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BCLI calls or request research access.

More BCLI calls Browse calls Request research access